Administration of antisense oligonucleotides to miR‐21 is able to ameliorate these effects, resulting in elevated levels of RECK and TIMP3, a reduction in MMP activity, and decreased migration and invasion of GBM cells 70. This evidence concerns the gene RECK and glioblastoma.